Skip to main content
Theralase Technologies Inc. logo

Theralase Technologies Inc. — Investor Relations & Filings

Ticker · TLT ISIN · CA88337V1004 LEI · 529900NI3Y8GLE2IBF28 TSXV Manufacturing
Filings indexed 698 across all filing types
Latest filing 2024-05-30 Regulatory Filings
Country CA Canada
Listing TSXV TLT

About Theralase Technologies Inc.

https://theralase.com/

Theralase Technologies Inc. designs, develops, manufactures, and markets patented laser technology platforms for both bio-stimulative and bio-destructive medical applications. The company operates two core divisions. The first is Cool Laser Therapy (CLT), which utilizes proprietary super-pulsed laser systems for therapeutic purposes, focusing on pain management, inflammation reduction, tissue repair, and the effective elimination of chronic knee pain. The second is Anti-Cancer Therapy (ACT), which employs patented light-activated Photo Dynamic Compounds (PDCs) combined with laser technology for destructive applications, specifically targeting the safe and effective destruction of cancer, bacteria, and viruses.

Recent filings

Filing Released Lang Actions
52-109F2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings
2024-05-30 English
News release - English.pdf
Regulatory Filings
2024-05-30 English
Certificate re dissemination to shareholders.pdf
Regulatory Filings
2024-05-29 English
Management information circular - English.pdf
Regulatory Filings
2024-05-28 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing the expansion of the clinical team at Theralase Technologies Inc. It details new hires and their roles related to ongoing clinical studies, specifically a Phase II bladder cancer clinical study. The text includes forward-looking statements about the company's plans and risks but does not contain any financial statements, detailed financial performance data, or regulatory filings. It is a corporate announcement about personnel changes and clinical study progress rather than a financial report, regulatory filing, or other specific report types. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous announcements that do not fit other categories.
2024-05-02 English
Report of exempt distribution (45-106F1).pdf
Regulatory Filings
2024-04-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.